SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-23-007828
Filing Date
2023-11-09
Accepted
2023-11-09 17:15:31
Documents
56
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT coeptis_i10q-093023.htm   iXBRL 10-Q 1434674
2 CERTIFICATION coeptis_ex3101.htm EX-31.1 8307
3 CERTIFICATION coeptis_ex3102.htm EX-31.2 8047
4 CERTIFICATION coeptis_ex3201.htm EX-32.1 2231
5 CERTIFICATION coeptis_ex3202.htm EX-32.2 2235
  Complete submission text file 0001683168-23-007828.txt   7674144

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE coep-20230930.xsd EX-101.SCH 47189
7 XBRL CALCULATION FILE coep-20230930_cal.xml EX-101.CAL 49390
8 XBRL DEFINITION FILE coep-20230930_def.xml EX-101.DEF 208504
9 XBRL LABEL FILE coep-20230930_lab.xml EX-101.LAB 306939
10 XBRL PRESENTATION FILE coep-20230930_pre.xml EX-101.PRE 265043
50 EXTRACTED XBRL INSTANCE DOCUMENT coeptis_i10q-093023_htm.xml XML 1674656
Mailing Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090
Business Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090 724-934-6467
Coeptis Therapeutics Holdings, Inc. (Filer) CIK: 0001759186 (see all company filings)

IRS No.: 981465952 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39669 | Film No.: 231393758
SIC: 2836 Biological Products, (No Diagnostic Substances)